Karen Y Fann, DO
Otolaryngology · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 31
- 7 carriers
- Office
- 1
Offices
1 location · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
31 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fann’s office at (408) 871-3400 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
31 of 31 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Anthem Prime (HMO-POS) | Anthem Blue Cross Partnership Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$62,507
Medicare paid this office $62,507 for 293 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 115 | $11,644 | $77 |
| Short return visit | 124 | $11,037 | $54 |
| New patient visit (30+ min) | 94 | $9,009 | $96 |
| Removal of impacted ear wax | 134 | $6,596 | $36 |
| Return visit (30+ min) | 26 | $3,406 | $117 |
See all 11 services
| Short return visit (20+ min) | 115 | $11,644 | $77 |
| Short return visit | 124 | $11,037 | $54 |
| New patient visit (30+ min) | 94 | $9,009 | $96 |
| Removal of impacted ear wax | 134 | $6,596 | $36 |
| Return visit (30+ min) | 26 | $3,406 | $117 |
| Exam of the nose and throat using an endoscope | 28 | $3,355 | $112 |
| Exam of ear using a microscope | 64 | $2,509 | $28 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $2,378 | $183 |
| New patient visit (45+ min) | 15 | $1,819 | $121 |
| New patient visit (15+ min) | 14 | $796 | $57 |
| Test to assess middle ear function | 18 | $334 | $15 |
Who their Medicare patients are
293 Original Medicare patients in 2024. Average age 77 · Women 63% · Also on Medicaid 25% · Health risk score 1.03. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 67% · Diabetes 30% · Coronary heart disease 25% · Chronic kidney disease 19% · Atrial fibrillation 15% · Cancer 13% · COPD 13% · Depression 12% · Heart failure 11% · Stroke 7% · Dementia 6%.
The office billed $271,207, Medicare allowed $88,841 and paid $62,507; for 914 services of 27 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 293 | 914 | 77 | 1.03 | $271,207 | $62,507 |
| 2023 | 273 | 859 | 77 | 1.11 | $246,288 | $58,487 |
| 2022 | 217 | 699 | 78 | 1.14 | $194,396 | $46,098 |
| 2021 | 180 | 603 | 78 | 1.05 | $169,388 | $41,829 |
| 2020 | 118 | 341 | 77 | 1.37 | $90,359 | $22,521 |
| 2019 | 260 | 835 | 78 | 1.37 | $134,186 | $49,122 |
| 2018 | 304 | 1,226 | 78 | 1.43 | $190,096 | $72,215 |
| 2017 | 283 | 1,015 | 77 | 1.25 | $141,725 | $55,532 |
| 2016 | 296 | 1,034 | 76 | 1.27 | $142,643 | $56,281 |
| 2015 | 287 | 1,061 | 75 | 1.42 | $160,324 | $65,838 |
| 2014 | 365 | 1,349 | 76 | 1.20 | $181,638 | $80,896 |
| 2013 | 356 | 1,141 | 76 | 1.35 | $172,379 | $73,190 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| Short return visit (20+ min) | 102 | $11,318 | $79 |
| Short return visit | 117 | $8,969 | $50 |
| New patient visit (30+ min) | 72 | $7,319 | $102 |
| Removal of impacted ear wax | 101 | $4,288 | $38 |
| New patient visit (45+ min) | 22 | $3,496 | $159 |
| Exam of ear using a microscope | 88 | $3,424 | $26 |
| New patient visit (15+ min) | 53 | $3,244 | $61 |
| Exam of the nose and throat using an endoscope | 24 | $3,121 | $111 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $2,660 | $177 |
| Return visit (30+ min) | 14 | $1,393 | $99 |
| Test to assess middle ear function | 21 | $520 | $16 |
2022: 7 services
| Short return visit (20+ min) | 82 | $10,300 | $80 |
| Short return visit | 83 | $7,270 | $50 |
| New patient visit (30+ min) | 64 | $6,115 | $96 |
| Exam of ear using a microscope | 91 | $3,932 | $26 |
| Exam of the nose and throat using an endoscope | 29 | $3,768 | $126 |
| New patient visit (15+ min) | 43 | $2,689 | $63 |
| Removal of impacted ear wax | 56 | $2,437 | $39 |
2021: 8 services
| Short return visit (20+ min) | 70 | $8,251 | $82 |
| Short return visit | 65 | $6,317 | $53 |
| Removal of impacted ear wax | 89 | $5,508 | $40 |
| New patient visit (30+ min) | 40 | $4,137 | $103 |
| New patient visit (15+ min) | 53 | $3,526 | $67 |
| Exam of the nose and throat using an endoscope | 22 | $3,266 | $109 |
| Return visit (30+ min) | 12 | $1,539 | $103 |
| Exam of ear using a microscope | 27 | $1,260 | $31 |
2020: 7 services
| Return visit (30+ min) | 37 | $4,320 | $96 |
| Short return visit (20+ min) | 36 | $3,186 | $68 |
| Removal of impacted ear wax | 53 | $3,047 | $40 |
| Exam of the nose and throat using an endoscope | 19 | $2,870 | $110 |
| New patient visit (30+ min) | 21 | $2,152 | $102 |
| New patient visit (15+ min) | 23 | $1,544 | $67 |
| Short return visit | 29 | $1,200 | $38 |
2019: 9 services
| Short return visit (20+ min) | 158 | $17,894 | $65 |
| New patient visit (30+ min) | 89 | $7,181 | $81 |
| Removal of impacted ear wax | 90 | $4,622 | $42 |
| Exam of the nose and throat using an endoscope | 27 | $2,986 | $107 |
| Return visit (30+ min) | 16 | $1,970 | $104 |
| Exam of ear using a microscope | 36 | $1,921 | $28 |
| Test for hearing various pitches using earphone and device placed against the bone | 45 | $1,821 | $38 |
| Test for ability to detect and repeat spoken words | 45 | $1,233 | $25 |
| Test for eardrum and muscle function | 53 | $1,176 | $20 |
2018: 11 services
| Short return visit (20+ min) | 207 | $25,516 | $63 |
| New patient visit (30+ min) | 146 | $12,352 | $85 |
| Removal of impacted ear wax | 108 | $6,989 | $43 |
| Test for hearing various pitches using earphone and device placed against the bone | 91 | $3,396 | $37 |
| Exam of the nose and throat using an endoscope | 26 | $2,921 | $112 |
| Test for ability to detect and repeat spoken words | 94 | $2,353 | $25 |
| Diagnostic exam of voice box using a flexible endoscope | 17 | $2,222 | $101 |
| Test for eardrum and muscle function | 101 | $1,966 | $18 |
| Exam of ear using a microscope | 28 | $1,473 | $29 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 28 | $1,384 | $49 |
| Short return visit | 17 | $849 | $33 |
2017: 9 services
| Short return visit (20+ min) | 187 | $19,248 | $60 |
| New patient visit (30+ min) | 127 | $11,219 | $88 |
| Removal of impacted ear wax | 103 | $6,132 | $42 |
| Test for hearing various pitches using earphone and device placed against the bone | 80 | $3,122 | $37 |
| Short return visit | 44 | $2,096 | $39 |
| Test for ability to detect and repeat spoken words | 81 | $2,060 | $24 |
| Test for eardrum and muscle function | 86 | $1,708 | $18 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $1,348 | $112 |
| Exam of ear using a microscope | 28 | $1,152 | $28 |
2016: 9 services
| Short return visit (20+ min) | 204 | $22,607 | $60 |
| New patient visit (30+ min) | 140 | $12,073 | $86 |
| Removal of impacted ear wax | 101 | $6,469 | $43 |
| Test for hearing various pitches using earphone and device placed against the bone | 75 | $2,797 | $35 |
| Test for ability to detect and repeat spoken words | 79 | $1,998 | $24 |
| Diagnostic exam of voice box using a flexible endoscope | 17 | $1,971 | $110 |
| Test for eardrum and muscle function | 84 | $1,596 | $18 |
| Exam of ear using a microscope | 25 | $1,228 | $27 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 13 | $646 | $50 |
2015: 9 services
| Short return visit (20+ min) | 204 | $24,808 | $63 |
| New patient visit (30+ min) | 126 | $11,004 | $87 |
| Removal of impacted ear wax | 103 | $6,815 | $43 |
| Test for hearing various pitches using earphone and device placed against the bone | 69 | $2,813 | $37 |
| Diagnostic exam of voice box using a flexible endoscope | 18 | $2,090 | $110 |
| Test for ability to detect and repeat spoken words | 72 | $1,895 | $24 |
| Test for eardrum and muscle function | 79 | $1,691 | $19 |
| Exam of ear using a microscope | 25 | $1,628 | $30 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 19 | $943 | $50 |
2014: 10 services
| Short return visit (20+ min) | 242 | $32,216 | $65 |
| New patient visit (30+ min) | 190 | $17,270 | $91 |
| Removal of impacted ear wax | 103 | $6,652 | $43 |
| Diagnostic exam of voice box using a flexible endoscope | 37 | $4,664 | $111 |
| Test for hearing various pitches using earphone and device placed against the bone | 96 | $3,604 | $37 |
| Test for ability to detect and repeat spoken words | 102 | $2,459 | $24 |
| Test for eardrum and muscle function | 109 | $2,184 | $19 |
| Exam of ear using a microscope | 34 | $1,981 | $29 |
| Simple control of nose bleed | 11 | $1,362 | $85 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 25 | $1,256 | $50 |
2013: 12 services
| Short return visit (20+ min) | 210 | $24,544 | $64 |
| New patient visit (30+ min) | 201 | $18,179 | $90 |
| Removal of impacted ear wax | 68 | $4,278 | $47 |
| Diagnostic exam of nasal passages using an endoscope | 12 | $3,295 | $220 |
| Comprehensive hearing and speech recognition test | 91 | $2,954 | $32 |
| Test for eardrum and muscle function | 122 | $2,482 | $19 |
| Exam of the nose and throat using an endoscope | 15 | $2,190 | $146 |
| Exam of ear using a microscope | 37 | $1,785 | $30 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $1,702 | $113 |
| Test for hearing various pitches using earphone and device placed against the bone | 30 | $1,224 | $41 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 16 | $807 | $50 |
| Test for ability to detect and repeat spoken words | 30 | $764 | $25 |
Medicaid work
$0 in 2022
Medicaid paid $0 for 16 billed services this clinician did in 2022, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 16 | $0 |
| 2022 | 16 | 1 | 15 | $0 |
| 2021 | 14 | 1 | 14 | $0 |
| 2019 | 425 | 5 | 43 | $77 |
| 2018 | 337 | 3 | 33 | $227 |
See the largest Medicaid services in earlier years
2021
| Short return visit (20+ min) | 14 | $0 |
2019
| Short return visit (20+ min) | 278 | $77 |
| Tympanometry and reflex threshold measurements | 40 | $0 |
| Comprehensive audiometry threshold evaluation and speech recognition | 28 | $0 |
| New patient visit (30+ min) | 61 | $0 |
| New patient visit (45+ min) | 18 | $0 |
2018
| New patient visit (30+ min) | 38 | $176 |
| Short return visit (20+ min) | 273 | $50 |
| New patient visit (45+ min) | 26 | $0 |
Drugs they prescribed that Part D paid
$25,152
Pharmacies billed $25,152 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
886 generic and fewer than 11 brand-name prescriptions · $25,152 in drug cost · 72 antibiotic prescriptions to 55 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 151 | $4,218 | $28 |
| Ipratropium | 65 | $3,543 | $55 |
| Fluticasone Propionate | 144 | $1,861 | $13 |
| Ciprofloxacin-Dexamethasone | 21 | $1,852 | $88 |
| Montelukast | 168 | $1,585 | $9 |
See all 14 drugs
| Azelastine | 151 | $4,218 | $28 |
| Ipratropium | 65 | $3,543 | $55 |
| Fluticasone Propionate | 144 | $1,861 | $13 |
| Ciprofloxacin-Dexamethasone | 21 | $1,852 | $88 |
| Montelukast | 168 | $1,585 | $9 |
| Fluocinolone Acetonide Oil | 36 | $1,385 | $38 |
| Mometasone Furoate | 35 | $991 | $28 |
| Omeprazole | 65 | $659 | $10 |
| Amoxicillin-Clavulanate Potass | 32 | $245 | $8 |
| Pantoprazole | 23 | $212 | $9 |
| Methylprednisolone | 16 | $100 | $6 |
| Hydrochlorothiazide | 17 | $36 | $2 |
| Azithromycin | 15 | $34 | $2 |
| Gabapentin | 12 | $19 | $2 |
Year by year
| 2024 | 912 | 268 | None | None | $25,152 |
| 2023 | 756 | 216 | None | None | $32,953 |
| 2022 | 688 | 211 | None | None | $31,498 |
| 2021 | 578 | 166 | None | 3% | $19,983 |
| 2020 | 307 | 107 | None | 8% | $13,020 |
| 2019 | 541 | 187 | None | 5% | $19,423 |
| 2018 | 788 | 206 | 2% (15) | 5% | $25,637 |
| 2017 | 775 | 223 | None | 4% | $24,503 |
| 2016 | 567 | 200 | None | 10% | $18,160 |
| 2015 | 522 | 173 | 3% (14) | 10% | $24,113 |
| 2014 | 545 | 182 | 3% (15) | 12% | $23,111 |
| 2013 | 375 | 152 | None | 14% | $15,390 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Azelastine | 127 | $5,761 | $45 |
| Ipratropium | 70 | $2,891 | $41 |
| Fluticasone Propionate | 133 | $2,587 | $19 |
| Ciprofloxacin-Dexamethasone | 20 | $2,545 | $127 |
| Fluocinolone Acetonide Oil | 34 | $2,291 | $67 |
| Mometasone Furoate | 28 | $1,638 | $58 |
| Montelukast | 95 | $1,555 | $16 |
| Omeprazole | 31 | $269 | $9 |
| Amoxicillin-Clavulanate Potass | 18 | $227 | $13 |
| Pantoprazole | 14 | $170 | $12 |
| Hydrochlorothiazide | 22 | $148 | $7 |
| Azithromycin | 23 | $145 | $6 |
| Methylprednisolone | 17 | $143 | $8 |
| Ciprofloxacin | 13 | $114 | $9 |
2022: 14 drugs
| Azelastine | 109 | $6,441 | $59 |
| Ciprofloxacin-Dexamethasone | 18 | $3,059 | $170 |
| Ipratropium | 48 | $2,652 | $55 |
| Fluocinolone Acetonide Oil | 28 | $2,430 | $87 |
| Mometasone Furoate | 30 | $1,691 | $56 |
| Fluticasone Propionate | 132 | $1,633 | $12 |
| Montelukast | 63 | $886 | $14 |
| Amoxicillin-Clavulanate Potass | 35 | $439 | $13 |
| Omeprazole | 48 | $423 | $9 |
| Spironolactone | 13 | $195 | $15 |
| Pantoprazole | 18 | $125 | $7 |
| Azithromycin | 19 | $125 | $7 |
| Hydrochlorothiazide | 23 | $115 | $5 |
| Ciprofloxacin | 11 | $65 | $6 |
2021: 15 drugs
| Azelastine | 42 | $2,394 | $57 |
| Ipratropium | 38 | $1,982 | $52 |
| Fluocinolone Acetonide Oil | 20 | $1,502 | $75 |
| Fluticasone Propionate | 101 | $1,465 | $15 |
| Mometasone Furoate | 32 | $1,302 | $41 |
| Omeprazole | 55 | $474 | $9 |
| Montelukast | 37 | $431 | $12 |
| Clarithromycin | 13 | $359 | $28 |
| Methylprednisolone | 25 | $347 | $14 |
| Triamterene-Hydrochlorothiazid | 19 | $326 | $17 |
| Amoxicillin-Clavulanate Potass | 34 | $313 | $9 |
| Mupirocin | 13 | $122 | $9 |
| Ciprofloxacin | 14 | $121 | $9 |
| Hydrochlorothiazide | 25 | $116 | $5 |
| Azithromycin | 17 | $101 | $6 |
2020: 10 drugs
| Ciprodex | 12 | $2,985 | $249 |
| Ipratropium | 22 | $1,936 | $88 |
| Azelastine | 18 | $1,355 | $75 |
| Mometasone Furoate | 25 | $618 | $25 |
| Fluticasone Propionate | 31 | $483 | $16 |
| Montelukast | 27 | $255 | $9 |
| Amoxicillin-Clavulanate Potass | 19 | $177 | $9 |
| Omeprazole | 12 | $83 | $7 |
| Azithromycin | 13 | $79 | $6 |
| Naproxen | 12 | $44 | $4 |
2019: 12 drugs
| Ciprodex | 21 | $4,955 | $236 |
| Fluocinolone Acetonide Oil | 23 | $2,596 | $113 |
| Azelastine | 67 | $2,385 | $36 |
| Ipratropium | 25 | $1,198 | $48 |
| Fluticasone Propionate | 81 | $1,010 | $12 |
| Montelukast | 85 | $859 | $10 |
| Mometasone Furoate | 32 | $487 | $15 |
| Amoxicillin-Clavulanate Potass | 30 | $336 | $11 |
| Hydrochlorothiazide | 26 | $222 | $9 |
| Methylprednisolone | 14 | $203 | $14 |
| Omeprazole | 28 | $197 | $7 |
| Azithromycin | 18 | $118 | $7 |
2018: 18 drugs
| Fluocinolone Acetonide Oil | 28 | $4,051 | $145 |
| Azelastine | 98 | $3,570 | $36 |
| Ciprodex | 12 | $2,620 | $218 |
| Neomycin-Polymyxin-Hc | 27 | $1,786 | $66 |
| Ipratropium | 61 | $1,691 | $28 |
| Fluticasone Propionate | 123 | $1,606 | $13 |
| Pilocarpine | 14 | $1,366 | $98 |
| Montelukast | 96 | $811 | $8 |
| Mometasone Furoate | 46 | $781 | $17 |
| Amoxicillin-Clavulanate Potass | 43 | $552 | $13 |
| Triamcinolone Acetonide | 11 | $453 | $41 |
| Omeprazole | 41 | $263 | $6 |
| Methylprednisolone | 19 | $263 | $14 |
| Pantoprazole | 17 | $136 | $8 |
| Hydrochlorothiazide | 19 | $135 | $7 |
| Azithromycin | 18 | $132 | $7 |
| Mupirocin | 12 | $117 | $10 |
| Ciprofloxacin | 11 | $106 | $10 |
2017: 15 drugs
| Fluocinolone Acetonide Oil | 37 | $6,611 | $179 |
| Ciprodex | 12 | $2,434 | $203 |
| Ipratropium | 62 | $2,055 | $33 |
| Fluticasone Propionate | 165 | $1,883 | $11 |
| Tobramycin-Dexamethasone | 17 | $1,441 | $85 |
| Neomycin-Polymyxin-Hc | 25 | $1,400 | $56 |
| Montelukast | 122 | $1,219 | $10 |
| Mometasone Furoate | 51 | $874 | $17 |
| Methylprednisolone | 25 | $401 | $16 |
| Amoxicillin-Clavulanate Potass | 25 | $359 | $14 |
| Mupirocin | 21 | $243 | $12 |
| Omeprazole | 31 | $238 | $8 |
| Triamterene-Hydrochlorothiazid | 19 | $217 | $11 |
| Pantoprazole | 22 | $149 | $7 |
| Azithromycin | 15 | $95 | $6 |
2016: 12 drugs
| Fluocinolone Acetonide Oil | 29 | $4,282 | $148 |
| Ciprodex | 11 | $2,127 | $193 |
| Fluticasone Propionate | 144 | $1,428 | $10 |
| Triamcinolone Acetonide | 16 | $982 | $61 |
| Montelukast | 63 | $900 | $14 |
| Mometasone Furoate | 47 | $842 | $18 |
| Neomycin-Polymyxin-Hc | 18 | $756 | $42 |
| Ipratropium | 25 | $495 | $20 |
| Methylprednisolone | 23 | $413 | $18 |
| Omeprazole | 26 | $235 | $9 |
| Pantoprazole | 17 | $171 | $10 |
| Azithromycin | 13 | $103 | $8 |
2015: 11 drugs
| Ciprodex | 20 | $3,456 | $173 |
| Fluocinolone Acetonide Oil | 19 | $3,148 | $166 |
| Fluticasone Propionate | 154 | $2,233 | $15 |
| Hydrocortisone Valerate | 19 | $2,099 | $110 |
| Rizatriptan | 12 | $1,359 | $113 |
| Montelukast | 52 | $955 | $18 |
| Methylprednisolone | 21 | $444 | $21 |
| Clindamycin | 13 | $331 | $25 |
| Amoxicillin-Clavulanate Potass | 19 | $274 | $14 |
| Omeprazole | 13 | $164 | $13 |
| Azithromycin | 13 | $100 | $8 |
2014: 11 drugs
| Ciprodex | 30 | $4,749 | $158 |
| Fluocinolone Acetonide Oil | 24 | $3,999 | $167 |
| Fluticasone Propionate | 183 | $3,101 | $17 |
| Montelukast | 78 | $1,398 | $18 |
| Clindamycin | 11 | $859 | $78 |
| Pilocarpine | 14 | $740 | $53 |
| Amox Tr-Potassium Clavulanate | 28 | $474 | $17 |
| Methylprednisolone | 18 | $425 | $24 |
| Neomycin-Polymyxin-Hc | 13 | $303 | $23 |
| Omeprazole | 27 | $277 | $10 |
| Azithromycin | 13 | $108 | $8 |
2013: 7 drugs
| Fluticasone Propionate | 113 | $2,781 | $25 |
| Nasonex | 14 | $1,956 | $140 |
| Ciprodex | 13 | $1,949 | $150 |
| Montelukast | 43 | $1,442 | $34 |
| Fluocinolone Acetonide Oil | 20 | $1,102 | $55 |
| Omeprazole | 31 | $417 | $13 |
| Methylprednisolone | 14 | $341 | $24 |
Money from drug and device companies
$67 in 2025
| 2025 | 2 | 3 | None | $67 |
| 2024 | 4 | 6 | None | $125 |
| 2023 | 3 | 4 | None | $75 |
| 2022 | 5 | 6 | None | $157 |
| 2021 | 2 | 9 | None | $166 |
| 2020 | 3 | 11 | None | $167 |
| 2019 | 4 | 14 | None | $525 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $52 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $15 | 1 payment
|
See all 3 published payments
| GlaxoSmithKline | Meals · 2025-12-10 | Nucala | $20 |
| Regeneron Healthcare Solutions | Meals · 2025-03-08 | Dupixent | $15 |
| GlaxoSmithKline | Meals · 2025-02-04 | Nucala | $32 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $125
| GlaxoSmithKline | Nucala | $56 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 2 payments
|
| Dynavax Technologies | Heplisav-B | $17 | 1 payment
|
| Optinose US | Xhance | $15 | 1 payment
|
2023: $75
| Optinose US | Xhance | $33 | 2 payments
|
| Regeneron Healthcare Solutions | Dupixent | $24 | 1 payment
|
| Genzyme | Dupixent | $18 | 1 payment
|
2022: $157
| Genzyme | Dupixent | $45 | 2 payments
|
| Stryker | Xpress Ent Dilation System | $32 | 1 payment
|
| Smith+Nephew | None | $30 | 1 payment
|
| OptiNose US | Xhance | $25 | 1 payment
|
| GlaxoSmithKline | Nucala | $24 | 1 payment
|
2021: $166
| Optinose US | Xhance | $152 | 8 payments
|
| Medtronic | Pteye | $14 | 1 payment
|
2020: $167
| OptiNose US | Xhance | $116 | 8 payments
|
| Genzyme | Dupixent | $33 | 2 payments
|
| Smith+Nephew | Werewolf | $18 | 1 payment
|
2019: $525
| OptiNose US | Xhance | $203 | 10 payments
|
| Regeneron Healthcare Solutions | Dupixent | $154 | 2 payments
|
| Genzyme | Dupixent | $122 | 1 payment
|
| Intersect ENT | Propel | $46 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 83.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1265635023
- Licence
- CA 20A9852
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 2495 Hospital Dr Ste 450, Mountain View, CA, 94040
- NPI first listed
- 2007-06-08
- NPI last updated
- 2020-11-11
- NPI record certified
- 2020-11-11
This is when the NPI record was last certified, not a medical board exam.